Neutrogena at AAD 2026: 20 Studies on Aging, Barrier, and UV Gaps
The 2026 American Academy of Dermatology (AAD) Annual Meeting ran March 27 through 31 in Denver, Colorado. Kenvue’s portfolio brands, Neutrogena, Aveeno, and Rogaine, came in with 20 research abstracts covering healthy aging, moisturization, sun protection, and acne. Here is what the data shows and what it means for daily skin decisions.
The shift from looking good to aging well
Kenvue surveyed 5,000 consumers and found that nearly 8 in 10 said they use skincare for prevention and healthy aging, not just for aesthetic improvement. That framing shift matters. It changes which ingredients consumers reach for, and how frequently.
Among adults under 40, acne ranked as the number one skin concern. Sun care continues to lag: only 17% of respondents listed it among their top three essential personal care steps. Dr. Michelle Bateson, VP and Head of North America R&D at Kenvue, noted that healthcare providers remain the most trusted voice for personal care advice, a dynamic the company addressed by launching the first-ever Resident’s Corner for dermatology trainees at this year’s meeting.
Neutrogena Collagen Bank Vitamin C Serum: 15% and barrier data
The Neutrogena Collagen Bank Vitamin C Serum delivers 15% vitamin C in a dual-action formulation. Testing in cellular and tissue models showed that it preserved skin barrier strength, a meaningful distinction given that high-concentration acids can sometimes compromise the very barrier they aim to support.
Vitamin C (ascorbic acid) is a cofactor in collagen synthesis. It drives the hydroxylation reactions that cross-link collagen fibers and simultaneously neutralizes free radicals from UV and pollution exposure. The clinically active range sits roughly between 10 and 20%, and 15% lands squarely in that window. The variable that separates products at this concentration is stability: how quickly the formula oxidizes, and whether active vitamin C is still present at the point of application.
Rapid Wrinkle Repair Retinol Pro+ .5%: the ceiling of OTC retinol
Neutrogena’s Rapid Wrinkle Repair Retinol Pro+ .5% Power Serum holds 0.5% pure retinol, the highest concentration available without a prescription in this category.
Retinol works by converting to retinoic acid in the skin, which then binds to nuclear receptors that accelerate cell turnover and signal for increased collagen production. It is among the most well-studied anti-aging ingredients in dermatology. Higher concentrations produce faster results and faster irritation. A sensible introduction: two to three nights per week for the first two weeks, adding nights from there based on how the skin responds. Always apply at night, as retinol breaks down under UV exposure.
Aveeno Skin Relief Healing Ointment: oat complex outpaces petrolatum
Aveeno Skin Relief Healing Ointment pairs Triple Oat with glycerin. Research presented at AAD showed it increased skin hydration levels and improved surface roughness, with superior moisturization compared to a leading petrolatum ointment.
Petrolatum (Vaseline) has long been the gold standard for occlusive moisturization. It works by forming a physical barrier that traps moisture underneath. The oat complex here operates through an additional mechanism: beta glucan and avenanthramides, compounds found in oats, actively support barrier repair and reduce inflammatory signals rather than simply sitting on top of the skin.
Aveeno Calm and Restore: oat activates the skin’s own hyaluronic acid
The Aveeno Calm and Restore formula combines oat flour with oat beta glucan. The AAD abstract showed it upregulates hyaluronic acid production in human fibroblasts (the cells responsible for making collagen and HA) and protects against UV-induced hyaluronic acid degradation.
Hyaluronic acid (HA) is the skin’s primary water-binding molecule. Production declines naturally with age, and UV accelerates that decline. Applying HA topically delivers temporary surface hydration. Stimulating the skin’s own fibroblasts to produce more is a different and more sustained approach, which is what this research proposes the oat complex achieves.
Neutrogena Hydro Boost: clinical data for post-procedure skin
Neutrogena Hydro Boost products generated new data on pre- and post-procedural skincare. Studies showed reduced redness after fraxel laser, microneedling, and chemical peel treatments.
This is a growing category. As in-clinic procedures become more routine, the recovery window, when the skin barrier is temporarily compromised, has become a recognized clinical consideration. The right moisturizer in that window can reduce downtime and protect the results of the procedure itself.
Neutrogena Clear Pore: 3.5% benzoyl peroxide with a gentleness claim
Neutrogena Clear Pore Cleanser/Mask uses 3.5% benzoyl peroxide (BPO) and demonstrated improved skin appearance while maintaining skin softness in testing.
Benzoyl peroxide is one of the few acne-fighting ingredients that directly kills P. acnes bacteria without generating antibiotic resistance, making it viable for long-term use. The 3.5% concentration balances efficacy with tolerability. The practical note for users: BPO bleaches fabric, so white towels and pillowcases are advisable.
BEMT and the UV gap that current sunscreens miss
Two sun protection themes stood out from Kenvue’s AAD presentations.
First, the ongoing research into BEMT (bis-ethylhexyloxyphenol methoxyphenyl triazine), a broad-spectrum UV filter currently under review for FDA approval in the United States. BEMT is already used in EU and Canadian formulations, where it is valued for its photostability and light texture. The US sunscreen ingredient list has not expanded significantly in decades, and BEMT represents one of the more advanced candidates in a slow regulatory pipeline.
Second, Neutrogena’s Helioplex 360 research examined boundary region light in the 380~430nm wavelength range, the spectral gap between traditional UVA coverage and visible light. This range is implicated in pigmentation and photoaging, yet most current sunscreen testing and labeling does not account for it.
What the 20 abstracts point toward
Across all 20 presentations, a common logic connects the research. Barrier integrity, hydration through cellular stimulation, UV protection beyond current standards, high-potency actives with tolerability data: each thread responds to a consumer who is thinking about skin as long-term health infrastructure, not a surface to be temporarily corrected.
That is the underlying bet in all of this. That prevention has become more motivating than treatment, and that ingredient research needs to meet that expectation with clinical rigor.